Corrigendum to: Shi-Bing Zhang, Ming Hong, Xiao-Yang Sun, Da Huang, Dan-Hua He, Yu-Fei Chen, Yong Yuan and Yong-Qiang Liu. 2022. Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2. Acta Materia Medica. Volume 1, Issue 3, pages 302–313. (DOI: 10.15212/AMM-2022-0011)
The authors regret that in Figure 2c , the image of SB (μM)-0 in the H1299 panel was inadvertently misused during the figure preparation. The correct images are shown below.
The authors would like to apologise for any inconvenience caused.